A study in CD248-deficient mice demonstrated that CD248 contributes to leukocyte accumulation and synovial hyperplasia in inflammatory arthritis, indicating that CD248 is a potential therapeutic target in RA [66]. Here, CD248 is linked to rheumatoid arthritis.